With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|The role of PDE4B in Racial Disparities in Outcome of Childhood Acute Lymphoblastic Leukemia||St. Jude Children's Research Hospital / Jun Yang||Young Investigator Grants||2010||Tennessee|
|The TC3 Line, a Zebrafish Model of T-Cell Malignancy||Huntsman Cancer Institute / Nathan Meeker, MD||Young Investigator Grants||2008||Utah|
|Novel Antibodies to the C2-set Domain of CD33 for Acute Myeloid Leukemia Immunotherapy||Fred Hutchinson Cancer Research Center / Colin Godwin, MD||Young Investigator Grants||2018||Washington|
|Targeting Protein Translation to Antagonize MYC-driven Neuroblastoma||Children's Hospital of Philadelphia / Andrea Flynn, MD||Young Investigator Grants||2017||Pennsylvania|
|Epigenomic Mechanisms of Neuroblastoma Tumorigenesis||Children's Hospital of Philadelphia / Jo Lynne Harenza, PhD||Young Investigator Grants||2017||Pennsylvania|
|The Role of Prmt1 in Osteosarcoma Initiation and Metastasis||Dana-Farber Cancer Institute / Hao-Ru Hsu, PhD||Young Investigator Grants||2013||Massachusetts|
|Identification of Resistance Mechanisms and Novel Therapeutic Strategies in Tyrosine Kinase Inhibitor Resistant FLT3/ITD Acute Myeloid Leukemia||Fred Hutchinson Cancer Research Center / Katherine Tarlock, MD||Young Investigator Grants||2014||Washington|
|Elucidating the Role of Human FAN1 Nuclease in DNA Crosslink Repair||Yale School of Medicine / Timsi Rao, PhD||Young Investigator Grants||2016||Connecticut|
|Activating Metabolic Pathways to Increase the Persistence of Leukemia Targeting T Cells||Children's Hospital of Pittsburgh / Erica Braverman, MD||Young Investigator Grants||2021||Pennsylvania|
|APOBEC3 in Pediatric Leukemia: a Biomarker for Sensitivity to PARP Inhibition?||Children's Hospital of Philadelphia / Abby Green, MD||Young Investigator Grants||2014||Pennsylvania|